GlassScriptPhysician profile
Irada Shapiro
NPI 1063504728
$4,462.10
in general payments reported to CMS, 2019-2025
28 companies · $682 in 2025
The $682 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $204 · 2021: $609 · 2022: $633 · 2023: $488 · 2024: $991 · 2025: $682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,072 · Education: $88.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,072.10 |
| Education | $88.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $630.42 | 2019-2025 | Kristalose |
| Astellas Pharma US INC | $424.58 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $354.86 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $351.58 | 2021-2025 | |
| Biogen, INC. | $317.29 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $304.88 | 2019-2023 | Qulipta, Lo Loestrin Fe |
| Evofem Biosciences, INC. | $283.46 | 2021-2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $247.49 | 2019-2024 | |
| Organon LLC | $206.54 | 2021-2025 | Nexplanon |
| Avion Pharmaceuticals | $200.73 | 2019-2021 | |
| Exeltis, USA INC. | $167.63 | 2019-2025 | Slynd |
| Roche Diagnostics Corporation | $159.88 | 2019 | |
| Merck Sharp & Dohme LLC | $119.28 | 2019-2021 | |
| Agile Therapeutics, INC. | $108.34 | 2023-2024 | Twirla |
| Therapeuticsmd, INC. | $88.23 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $80.43 | 2022 | |
| Amag Pharmaceuticals, INC. | $59.00 | 2019 | |
| Coopersurgical, INC. | $55.13 | 2019-2023 | Paragard T 380a |
| Mission Pharmacal Company | $52.72 | 2019 | |
| Hologic Sales and Service, LLC | $45.32 | 2024 | Thinprep 2000 Processor, Aptima |
| Allergan, INC. | $43.86 | 2019 | |
| Duchesnay USA Incorporated | $39.61 | 2019 | |
| Horizon Therapeutics Plc | $29.42 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.88 | 2022 | |
| Intra-Sana Laboratories | $22.61 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.04 | 2022 | |
| Lupin INC. | $14.41 | 2019 | |
| Millicent US INC | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irada Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.